Fig. 8
From: Body mass index-associated molecular characteristics involved in tumor immune and metabolic pathways
The chariotries of metabolism pathways in different BMI groups. a The composite expression of each metabolism pathway genes in normal, overweight, and obesity patients across all tumor types, with statistical significance calculated by the Kruskal-Wallis rank-sum test. *p value < 0.05, **p value < 0.01, ***p value < 0.001, and ****p value < 0.0001. b The proportion of metabolic pathways enriched patients in excess weight group. Each point represents a metabolic pathway in each tumor type with the size corresponding to the percent of enriched patients. Filled points corresponding to significant enrichment difference of metabolic pathway between normal and excess weight patients